Alcohol increases tumor necrosis factor α and decreases nuclear factor-κB to activate hepatic apoptosis in genetically obese mice

Hepatology

Volumn 42, Issue 6, 2005, Pages 1280-1290

  Robin, Marie Anne ^a   Demeilliers, Christine ^a   Sutton, Angéla ^a   Paradis, Valérie ^b   Maisonneuve, Caroline ^a   Dubois, Sylvie ^b   Poirel, Odile ^a   Lettéron, Philippe ^a   Pessayre, Dominique ^a   Fromenty, Bernard ^a  

^a INSERM   (France)

^b BEAUJON HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; CASPASE 3; COPPER ZINC SUPEROXIDE DISMUTASE; CYTOCHROME C; CYTOCHROME P450 2E1; DNA FRAGMENT; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; HEAT SHOCK PROTEIN 70; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MANGANESE SUPEROXIDE DISMUTASE; MITOCHONDRIAL DNA; PENTOXIFYLLINE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ALCOHOL BLOOD LEVEL; ALCOHOL INTOXICATION; ALCOHOL LIVER CIRRHOSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA BINDING; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; LIPID PEROXIDATION; LIVER CELL; LIVER HISTOLOGY; MALE; MOUSE; NICK END LABELING; NONHUMAN; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN LOCALIZATION;

EID: 28844465328     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20949     Document Type: Article

References (56)

1. Iturriaga H, Bunout D, Hirsch S, Ugarte G. Overweight as a risk factor or a predictive sign of histological liver damage in alcoholics. Am J Clin Nutr 1988;47:235-238.
2. Naveau S, Giraud V, Bototto E, Aubert A, Capron F, Chaput JC. Excess weight risk factor for alcoholic liver disease. HEPATOLOGY 1997;25:108-111.
3. Bellentani S, Saccoccio G, Masutti F, Grocè LS, Brandi G, Sasso F, et al. Prevalence and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 2000;132:112-117.
4. Chitturi S, Farrell GC. Etiopathogenesis of nonalcoholic steatohepatitis. Semin Liver Dis 2001;21:27-41.
5. Pessayre D, Mansouri A, Fromenty B. Nonalcoholic steatosis and steatohepatitis V: Mitochondrial dysfunction in steatohepatitis. Am J Physiol Gastrointest Liver Physiol 2002;282:G193-G199.
6. Tilg H, Diehl AM. Cytokines in alcoholic and nonalcoholic steatohepatitis. N Engl J Med 2000;343:1467-1476.
7. Galle PR, Hofmann WJ, Walczak H, Schaller H, Otto G, Stremmel W, et al. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med 1995;182:1223-1230.
8. Natori S, Rust C, Stadheim LM, Srinivasan A, Burgart LJ, Gores GJ. Hepatocyte apoptosis is a pathologic feature of human alcoholic hepatitis. J Hepatol 2001;34:248-253.
9. Feldmann G, Haouzi D, Moreau A, Durand-Schneider AM, Bringuier A, Berson A, et al. Opening of the mitochondrial permeability transition pore causes matrix expansion and outer membrane rupture in Fas-mediated hepatic apoptosis in mice. HEPATOLOGY 2000;31:674-683.
10. Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature 1998;395:763-770.
11. Lin HZ, Yang SQ, Chuckaree C, Kuhajda F, Ronnet G, Diehl AM. Metformin reverses fatty liver disease in obese, leptin-deficient mice. Nature Med 2000;6:998-1003.
12. Yang S, Lin HZ, Hwang J, Chacko VP, Diehl AM. Hepatic hyperplasia in noncirrhotic livers: is obesity-related hepatic steatosis a premalignant condition? Cancer Res 2001;61:5016-5023.
13. Li Z, Yang S, Lin H, Huang J, Watkins PA, Moser AB, et al. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. HEPATOLOGY 2003;37:343-350.
14. Tang M, Potter JJ, Mezey E. Leptin enhances the effect of transforming growth factor β in increasing type I collagen formation. Biochem Biophys Res Commun 2002;297:906-911.
15. Yang SQ, Lin HZ, Lane MD, Clemens M, Diehl AM. Obesity increases sensitivity to endotoxin liver injury: implication for the pathogenesis of steatohepatitis. Proc Natl Acad Sci U S A 1997;94:2557-2562.
16. Faggioni R, Jones-Carson J, Reed DA, Dinarello CA, Feingold KR, Grunfeld C, et al. Leptin-deficient (ob/ob) mice are protected from T-cell mediated hepatotoxicity: role of tumor necrosis factor alpha and IL-18. Proc Natl Acad Sci U S A 2000;97:2367-2372.
17. Doi T, Marino MW, Takahashi T, Yoshida T, Sakakura T, Old LJ, et al. Absence of tumor necrosis factor rescues RelA-deficient mice from embryonic lethality. Proc Natl Acad Sci U S A 1999;96:2994-2999.
18. Imose M, Nagaki M, Osawa Y, Brenner DA, Asano T, Hayashi H, et al. Inhibition of nuclear factor kappaB and phosphatidylinositol 3-kinase/Akt is essential for massive hepatocyte apoptosis induced by tumor necrosis factor alpha in mice. Liver Int 2003;23:386-396.
19. Dudley E, Hornung F, Zheng L, Scherer D, Ballard D, Lenardo M. NF-kappaB regulates Fas/APO-1/CD95- and TCR-mediated apoptosis of T lymphocytes. Eur J Immunol 1999;29:878-886.
20. Guo G, Yan-Sanders Y, Lyn-Cook BD, Wang T, Tamae D, Ogi J, et al. Manganese superoxide dismutase-mediated gene expression in radiation-induced adaptive responses. Mol Cell Biol 2003;23:2362-2378.
21. Wu D, Cederbaum A. Glutathione depletion in CYP2E1-expressing liver cells induces toxicity due to the activation of p38 mitogen-activated protein kinase and reduction of nuclear factor-κB DNA binding activity. Mol Pharmacol 2004;66:749-760.
22. Romics L, Kodys K, Dolganiuc A, Graham L, Velayudham A, Mandrekar P, et al. Diverse regulation of NF-κ and peroxisome proliferator-activated receptors in murine nonalcoholic fatty liver. HEPATOLOGY 2004;40:376-385.
23. Carmiel-Haggai M, Cederbaum AI, Nieto N. Binge ethanol exposure increases liver injury in obese rats. Gastroenterology 2003;125:1818-1833.
24. Morgan TR, McClain CJ. Pentoxifylline and alcoholic hepatitis. Gastroenterology 2000;119:1787-1791.
25. Raza H, Prabu SK, Robin MA, Avadhani NG. Elevated mitochondrial cytochrome P450 2E1 and glutathione S-transferase A4-4 in streptozotocin-induced diabetic rats: tissue-specific variations and roles in oxidative stress. Diabetes 2004;53:185-194.
26. Zhou D, Brown SA, Yu T, Chen G, Barve S, Kang BC, et al. A high dose of ionizing radiation induces tissue-specific activation of nuclear factor-kappaB in vivo. Radiat Res 1999;151:703-709.
27. Griffith OW. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal Biochem 1980;106:207-212.
28. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues with thiobarbituric acid reaction. Anal Biochem 1979;95:351-358.
29. Mansouri A, Gaou I, De Kerguenec C, Amsellem S, Haouzi D, Berson A, et al. An alcoholic binge causes massive degradation of hepatic mitochondrial DNA in mice. Gastroenterology 1999;117:181-190.
30. Demeilliers C, Maisonneuve C, Grodet A, Mansouri A, Nguyen R, Tinel M, et al. Impaired adaptive resynthesis and prolonged depletion of hepatic mitochondrial DNA after repeated alcohol binges in mice. Gastroenterology 2002;123:1278-1290.
31. Sutton A, Khoury H, Prip-Buus C, Cepanec C, Pessayre D, Degoul F. The Ala16Val genetic dimorphism modulates the import of human manganese superoxide dismutase into rat liver mitochondria. Pharmacogenetics 2003;13:145-157.
32. Habig WH, Pabst MJ, Jakoby WB. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 1974;249:7130-7139.
33. Prohaska JR, Ganther HE. Glutathione peroxidase activity of glutathione-S-transferases purified from rat liver. Biochem Biophys Res Commun 1976;76:437-445.
34. Calberg I, Mannervik B. Glutathione reductase. Methods Enzymol 1985;113:484-490.
35. Imai Y, Ito A, Sato R. Evidence for biochemically different types of vesicles in the hepatic microsomal fraction. J Biochem 1966;60:417-428.
36. Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin AS. NF-κB antiapoptosis: induction of TRAF1 andTRAF2 and c-IAP1 and C-IAP2 to suppress caspase-8 activation. Science 1998;281:1680-1683.
37. Cahill A, Cunningham CC, Adachi M, Ishii H, Bailey SM, Fromenty B, et al. Effects of alcohol and oxidative stress on liver pathology: the role of the mitochondrion. Alcohol Clin Exp Res 2002;26:907-915.
38. Degoul F, Sutton A, Mansouri A, Cepanec C, Degott C, Fromenty B, et al. Homozygosity for alanine in the mitochondrial targeting sequence of superoxide dismutase and risk for severe alcoholic liver disease. Gastroenterology 2001;120:1468-1474.
39. Calabrese V, Testa G, Ravagna A, Bates TE, Stella AM. HSP70 induction in the brain following ethanol administration in the rat: regulation by glutathione redox state. Biochem Biophys Res Commun 2000;269:397-400.
40. Fromenty B, Pessayre D. Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity. Pharmacol Ther 1995;67:101-154.
41. Grasl-Kraupp B, Ruttkay-Nedecky B, Koudelka H, Bukowska K, Bursch W, Shulte-Hermann R. In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note. HEPATOLOGY 1995;21:1465-1468.
42. Enomoto N, Takei Y, Hirose M, Ikejima K, Miwa H, Kitamura T, et al. Thalidomide prevents alcoholic liver injury in rats through suppression of Kupffer cell sensitization and TNF-α production. Gastroenterology 2002;123:291-300.
43. Andrés D, Diez-Fernandez C, Castrillo A, Cascales M. Relationship between the activation of heat shock factor and the suppression of nuclear factor-κB activity in rat hepatocyte cultures treated with cyclosporine A. Biochem Pharmacol 2002;64:247-256.
44. Ran R, Lu A, Zhang L, Tang Y, Zhu H, Xu H, et al. Hsp70 promotes TNF-mediated apoptosis by binding IKK gamma and impairing NF-kappaB survival signaling. Genes Dev 2004;18:1466-1481.
45. Kaltschmidt B, Kaltschmidt C, Hofmann TG, Hehner SP, Droge W, Schmitz ML. The pro- or anti-apoptotic function of NF-kappaB is determined by the nature of the apoptotic stimulus. Eur J Biochem 2000;267:3828-3835.
46. Canbay A, Taimr P, Torok N, Higuchi H, Friedman S, Gores GJ. Apoptotic body engulfment by a human stellate cell line is profibrogenic. Lab Invest 2003;83:655-663.
47. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest 1998;101:890-898.
48. Fromenty B, Robin MA, Igoudjil A, Mansouri A, Pessayre D. The ins and out of mitochondrial dysfunction in NASH. Diabetes Metab 2004;30:121-138.
49. Yang SQ, Zhu H, Li Y, Lin HZ, Gabrielson K, Trush MA, et al. Mitochondrial adaptations to obesity-related oxidant stress. Arch Biochem Biophys 2000;378:259-268.
50. Gao D, Wei C, Chen L, Huang J, Yang S, Diehl AM. Oxidative DNA damage and DNA repair enzyme expression are inversely related in murine models of fatty liver disease. Am J Physiol Gastrointest Liver Physiol 2004;287:G1070-G1077.
51. Suliman HB, Carraway MS, Welty-Wolf KE, Whorton AR, Piantadosi CA. Lipopolysaccharide stimulates mitochondrial biogenesis via activation of nuclear respiratory factor-1. J Biol Chem 2003;278:41510-41518.
52. Herzig RP, Scacco S, Scarpulla RC. Sequential serum-dependent activation of CREB and NRf-1 leads to enhanced mitochondrial respiration through the induction of cytochrome c. J Biol Chem 2000;275:13134-13141.
53. Kowaltowski AJ, Vercesi AE. Reactive oxygen generation by mitochondria. In: Lemasters JJ, Nieminen AL, eds. Mitochondria in Pathogenesis, New York: Kluwer Academic/Plenum Publishers, 2001:281-300.
54. Lee HC, Lu CY, Fahn HJ, Wei YH. Aging- and smoking-associated alteration in the relative content of mitochondrial DNA in human lung. FEBS Lett 1998;441:292-296.
55. Lee HC, Yin PH, Lu CY, Chi CW, Wei YH. Increase of mitochondria and mitochondrial DNA in response to oxidative stress in human cells. Biochem J 2000;348:425-432.
56. Voisine C, Craig EA, Zufall N, von Ahsen O, Pfanner N, Voos W. The protein import motor of mitochondria: unfolding and trapping of preproteins are distinct and separable functions of matrix Hsp70. Cell 1999;97:565-574.